Therefore, in this study, the expression of immunosuppressive (PD-L1 and PD-L2) and cholinergic (M3R, α7nAChR, and ChAT) markers was correlated with CRC stages (I-IV), patients’ age, gender, risk, and survival outcomes. The gene discussed is PDCD1LG2; the disease is colorectal carcinoma.